Heron Therapeutics Announces Appointment of Ira Duarte as Chief Financial Officer
SAN DIEGO, June 23, 2023 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet...
Source: marketscreener.com
